世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アジア太平洋地域の幹細胞市場予測 2019-2027年

ASIA PACIFIC STEM CELL MARKET FORECAST 2019-2027

 

出版社 出版年月電子版価格 ページ数
Inkwood Research
インクウッドリサーチ
2019年7月US$1,250
シングルユーザライセンス(印刷不可PDF)
138

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

サマリー

この調査レポートはアジア太平洋地域の幹細胞市場を分析・予測したInkwood Researchの市場調査報告書です。

Overview

KEY FINDINGS

The Asia-Pacific stem cell market is anticipated to rise with the fastest CAGR of 9.89% over the projected years of 2019-2027. Chronic diseases like cancers have seen a considerable rise in the Asia Pacific region. As a result, the demand for stem cell market is further expected to rise in this region.
MARKET INSIGHTS
The China stem cell market contributed significant amounts of revenue share in 2018. A growing elderly population and fundamental progress in clinical stem cell research are factors which are majorly driving this country’s growth. The other countries analyzed in this report include India, Japan, South Korea, Australia and a few others in the Rest of Asia Pacific regional segment. Among these, momentous growth is expected from the Japan stem cell market. Japan currently plays a significant role in the cancer stem cell market in the Asia Pacific region and the Japanese government is heavily investing in the healthcare industry in order to improve the healthcare facilities in the country.
COMPETITIVE INSIGHTS
Some of the leading players in this market are Pluristem Therapeutics Inc., Vericel Corporation (formerly Aastrom Bioscience), Qiagen N.V., Fibrocell Science Inc., International Stem Cell Corp., Cellular Engineering Technologies, Inc., StemCell Technologies, Cytori Therapeutics, Cellular Dynamics International (Holding Company Fujifilm), GE Healthcare, Biotime Inc. etc.



目次

Table of Contents

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2.

KEY FINDINGS

3.2.1. REGENERATIVE MEDICINE IS THE EMERGING BRANCH OF MEDICAL SCIENCE
3.2.2. USE OF ADULT STEM CELL HAS BEEN SIGNIFICANT
3.2.3. INDUCED PLURIPOTENT IS THE FASTEST GROWING STEM CELL PRODUCT
3.2.4. STEM CELL ACQUISITION IS THE HIGHEST REVENUE GENERATING TECHNOLOGY SEGMENT
3.2.5. ORTHOPEDIC TREATMENTS IS THE WIDELY USED STEM CELL THERAPEUTIC APPLICATION
3.2.6. AUTOLOGIC STEM CELL THERAPY TREATMENT TYPE IS ANTICIPATED TO GROW SIGNIFICANTLY OVER THE FORECAST PERIOD
4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVER
4.2.1. POTENTIAL OF STEM CELL IN REGENERATIVE MEDICINE
4.2.2. KEY TO ANTI-AGEING AND PROLONGING LIFE
4.2.3. INCREASING R&D INVESTMENTS IN ADULT STEM CELL RESEARCH
4.2.4. EASE OF ADMINISTRATION
4.2.5. REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
4.2.6. FEDERAL FUNDING FOR STEM CELL RESEARCH
4.2.7. RISING AWARENESS ABOUT UMBILICAL CORD STEM CELL
4.2.8. RISING NUMBER OF CLINICAL TRIALS ASSOCIATED WITH STEM CELL RESEARCH
4.3. MARKET RESTRAINTS
4.3.1. SAFETY ISSUES
4.3.2. ETHICAL ISSUES
4.3.3. HIGH COST ASSOCIATED WITH STEM CELL PROCEDURES
4.4. OPPORTUNITIES
4.4.1. TECHNOLOGICAL INNOVATIONS
4.4.2. EMERGING APPLICATION AS A DRUG DISCOVERY TOOL
4.4.3. OTHER PROMISING APPLICATIONS
4.5. MARKET CHALLENGES
4.5.1. STRINGENT GOVERNMENT REGULATIONS
4.5.2. LACK OF LEGISLATION
5. MARKET BY PRODUCTS
5.1. ADULT STEM CELL MARKET
5.1.1. HEMATOPOIETIC STEM CELL MARKET
5.1.2. MESENCHYMAL STEM CELL MARKET
5.1.3. NEURAL STEM CELL MARKET
5.1.4. DENTAL STEM CELL MARKET
5.1.5. UMBILICAL CORD STEM CELL MARKET
5.2. HUMAN EMBRYONIC STEM CELL
5.3. INDUCED PLURIPOTENT STEM CELL MARKET
5.4. RAT NEURAL STEM CELL MARKET
6. MARKET BY TECHNOLOGY
6.1. STEM CELL ACQUISITION
6.1.1. STEM CELL BONE MARROW MARKET
6.1.2. STEM CELL APHERESIS MARKET
6.1.3. UMBILICAL CORD BLOOD MARKET
6.2. STEM CELL PRODUCTION
6.2.1. THERAPEUTIC CLONING
6.2.2. IVF STEM CELL
6.2.3. STEM CELL CULTURE
6.3. STEM CELL CRYOPRESERVATION
6.4. STEM CELL EXPANSION AND SUB-CULTURE
7. MARKET BY APPLICATION
7.1. REGENERATIVE MEDICINE
7.2. DRUG DISCOVERY AND DEVELOPMENT
8. MARKET BY THERAPEUTIC APPLICATION
8.1. NEUROLOGICAL DISORDERS
8.2. ORTHOPEDIC TREATMENTS
8.3. ONCOLOGY DISORDERS
8.4. DIABETES
8.5. INJURIES AND WOUNDS
8.6. CARDIOVASCULAR DISORDERS
8.7. OTHER THERAPEUTIC APPLICATIONS
9. MARKET BY TREATMENT TYPE
9.1. ALLOGENEIC STEM CELL THERAPY
9.2. AUTOLOGIC STEM CELL THERAPY
9.3. SYNGENEIC STEM CELL THERAPY
10. KEY ANALYTICS
10.1. PORTER’S FIVE FORCES ANALYSIS
10.1.1. THREAT OF NEW ENTRANTS
10.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
10.1.3. BARGAINING POWER OF BUYER
10.1.4. BARGAINING POWER OF SUPPLIER
10.1.5. INTENSITY OF COMPETITIVE RIVALRY
10.2. VALUE CHAIN ANALYSIS
10.3. OPPORTUNITY MATRIX
10.4. KEY BUYING CRITERIA
10.4.1. HIGH PRICE
10.4.2. EFFICACY
10.4.3. APPLICATION AND EFFECTIVENESS
10.4.4. ACCURACY
10.5. PEST ANALYSIS
10.6. HISTORY OF STEM CELL
10.7. PATENT ANALYSIS
10.7.1. STEM CELL PATENT IN ASIA PACIFIC
10.8. REGULATORY FRAMEWORK
11. GEOGRAPHICAL ANALYSIS
11.1. ASIA PACIFIC (APAC)
11.1.1. INDIA
11.1.2. CHINA
11.1.3. JAPAN
11.1.4. AUSTRALIA
11.1.5. SOUTH KOREA
11.1.6. REST OF ASIA PACIFIC
12. COMPETITIVE LANDSCAPE
12.1. MARKET SHARE ANALYSIS
12.2. COMPANY PROFILE
12.2.1. BECTON DICKINSON AND COMPANY
12.2.2. BIOTIME INC.
12.2.3. BRAINSTORM CELL THERAPEUTICS
12.2.4. CELGENE CORPORATION
12.2.5. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
12.2.6. CELLULAR ENGINEERING TECHNOLOGIES, INC.
12.2.7. CORNING INC.
12.2.8. CYTORI THERAPEUTICS
12.2.9. FIBROCELL SCIENCE INC.
12.2.10. GE HEALTHCARE
12.2.11. INTERNATIONAL STEM CELL CORP.
12.2.12. STEMEDICA CELL TECHNOLOGIES INC.
12.2.13. STRYKER CORPORATION
12.2.14. TAKARA HOLDINGS INC.
12.2.15. THERMO FISHER
12.2.16. VERICEL CORPORATION (FORMERLY AASTROM BIOSCIENCE)
12.2.17. PLURISTEM THERAPEUTICS INC.
12.2.18. QIAGEN N.V.
12.2.19. STEMCELL TECHNOLOGIES



LIST OF TABLES
TABLE 1 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC STEM CELL MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC STEM CELL MARKET IN ADULT STEM CELL 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC ADULT STEM CELL MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC HEMATOPOIETIC STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC MESENCHYMAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC NEURAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC DENTAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC UMBILICAL CORD STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC HUMAN EMBRYONIC STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC RAT NEURAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC STEM CELL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC STEM CELL ACQUISITION MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC STEM CELL BONE MARROW MARKET BY REGIONS 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC STEM CELL APHERESIS MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC UMBILICAL CORD BLOOD MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC STEM CELL PRODUCTION MARKET 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC THERAPEUTIC CLONING MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC IVF STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC STEM CELL CULTURE MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC STEM CELL CRYOPRESERVATION MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC STEM CELL EXPANSION AND SUB-CULTURE MARKET 2019-2027 ($ MILLION)
TABLE 26 ASIA PACIFIC STEM CELL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 27 ASIA PACIFIC REGENERATIVE MEDICINE MARKET 2019-2027 ($ MILLION)
TABLE 28 ASIA PACIFIC DRUG DISCOVERY AND DEVELOPMENT MARKET 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC STEM CELL MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC NEUROLOGICAL DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 31 ASIA PACIFIC ORTHOPEDIC TREATMENTS MARKET 2019-2027 ($ MILLION)
TABLE 32 ASIA PACIFIC ONCOLOGY DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 33 ASIA PACIFIC DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 34 ASIA PACIFIC INJURIES AND WOUNDS MARKET 2019-2027 ($ MILLION)
TABLE 35 ASIA PACIFIC CARDIOVASCULAR DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 36 ASIA PACIFIC OTHER THERAPEUTIC APPLICATIONS BACK 2019-2027 ($ MILLION)
TABLE 37 ASIA PACIFIC STEM CELL MARKET BY TREATMENT TYPE 2019-2027 ($ MILLION)
TABLE 38 ASIA PACIFIC ALLOGENEIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 39 ASIA PACIFIC AUTOLOGIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 40 ASIA PACIFIC SYNGENEIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 41 ASIA PACIFIC STEM CELL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 42 STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC ADULT STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 3 ASIA PACIFIC ADULT STEM CELL MARKET BY HEMATOPOIETIC STEM CELL 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC ADULT STEM CELL MARKET BY MESENCHYMAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC ADULT STEM CELL MARKET BY NEURAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC ADULT STEM CELL MARKET BY DENTAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC ADULT STEM CELL MARKET BY UMBILICAL CORD STEM CELL 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC STEM CELL MARKET BY HUMAN EMBRYONIC STEM CELL 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC STEM CELL MARKET BY INDUCED PLURIPOTENT STEM CELL 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC STEM CELL MARKET BY RAT NEURAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC STEM CELL MARKET BY ACQUISITION 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY BONE MARROW 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY CELL APHERESIS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY UMBILICAL CORD BLOOD 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC STEM CELL MARKET BY PRODUCTION 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY THERAPEUTIC CLONING 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY IVF STEM CELL 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY STEM CELL CULTURE 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC STEM CELL MARKET BY STEM CELL CRYOPRESERVATION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC STEM CELL MARKET BY STEM CELL EXPANSION AND SUB-CULTURE 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC STEM CELL MARKET BY REGENERATIVE MEDICINE 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC STEM CELL MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC STEM CELL MARKET BY NEUROLOGICAL DISORDERS 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC STEM CELL MARKET BY ORTHOPEDIC TREATMENTS 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC STEM CELL MARKET BY ONCOLOGY DISORDERS 2019-2027 ($ MILLION)
FIGURE 26 ASIA PACIFIC STEM CELL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 27 ASIA PACIFIC STEM CELL MARKET BY INJURIES AND WOUNDS 2019-2027 ($ MILLION)
FIGURE 28 ASIA PACIFIC STEM CELL MARKET BY CARDIOVASCULAR DISORDERS 2019-2027 ($ MILLION)
FIGURE 29 ASIA PACIFIC STEM CELL MARKET BY OTHER THERAPEUTIC APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 30 ASIA PACIFIC STEM CELL MARKET BY ALLOGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 31 ASIA PACIFIC STEM CELL MARKET BY AUTOLOGIC STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 32 ASIA PACIFIC STEM CELL MARKET BY SYNGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 33 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 34 INDIA STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 35 CHINA STEM CELL MARKET 2019-2027($ MILLION)
FIGURE 36 JAPAN STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 37 AUSTRALIA STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 38 SOUTH KOREA STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 39 REST OF APAC STEM CELL MARKET 2019-2027($ MILLION)
FIGURE 40 STEM CELL MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)

List of Tables

LIST OF TABLES
TABLE 1 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 2 ASIA PACIFIC STEM CELL MARKET BY PRODUCT 2019-2027 ($ MILLION)
TABLE 3 ASIA PACIFIC STEM CELL MARKET IN ADULT STEM CELL 2019-2027 ($ MILLION)
TABLE 4 ASIA PACIFIC ADULT STEM CELL MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 5 ASIA PACIFIC HEMATOPOIETIC STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 6 ASIA PACIFIC MESENCHYMAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 7 ASIA PACIFIC NEURAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 8 ASIA PACIFIC DENTAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 9 ASIA PACIFIC UMBILICAL CORD STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 10 ASIA PACIFIC HUMAN EMBRYONIC STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 11 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 12 ASIA PACIFIC RAT NEURAL STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 13 ASIA PACIFIC STEM CELL MARKET BY TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 14 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 15 ASIA PACIFIC STEM CELL ACQUISITION MARKET 2019-2027 ($ MILLION)
TABLE 16 ASIA PACIFIC STEM CELL BONE MARROW MARKET BY REGIONS 2019-2027 ($ MILLION)
TABLE 17 ASIA PACIFIC STEM CELL APHERESIS MARKET 2019-2027 ($ MILLION)
TABLE 18 ASIA PACIFIC UMBILICAL CORD BLOOD MARKET 2019-2027 ($ MILLION)
TABLE 19 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 20 ASIA PACIFIC STEM CELL PRODUCTION MARKET 2019-2027 ($ MILLION)
TABLE 21 ASIA PACIFIC THERAPEUTIC CLONING MARKET 2019-2027 ($ MILLION)
TABLE 22 ASIA PACIFIC IVF STEM CELL MARKET 2019-2027 ($ MILLION)
TABLE 23 ASIA PACIFIC STEM CELL CULTURE MARKET 2019-2027 ($ MILLION)
TABLE 24 ASIA PACIFIC STEM CELL CRYOPRESERVATION MARKET 2019-2027 ($ MILLION)
TABLE 25 ASIA PACIFIC STEM CELL EXPANSION AND SUB-CULTURE MARKET 2019-2027 ($ MILLION)
TABLE 26 ASIA PACIFIC STEM CELL MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 27 ASIA PACIFIC REGENERATIVE MEDICINE MARKET 2019-2027 ($ MILLION)
TABLE 28 ASIA PACIFIC DRUG DISCOVERY AND DEVELOPMENT MARKET 2019-2027 ($ MILLION)
TABLE 29 ASIA PACIFIC STEM CELL MARKET BY THERAPEUTIC APPLICATION 2019-2027 ($ MILLION)
TABLE 30 ASIA PACIFIC NEUROLOGICAL DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 31 ASIA PACIFIC ORTHOPEDIC TREATMENTS MARKET 2019-2027 ($ MILLION)
TABLE 32 ASIA PACIFIC ONCOLOGY DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 33 ASIA PACIFIC DIABETES MARKET 2019-2027 ($ MILLION)
TABLE 34 ASIA PACIFIC INJURIES AND WOUNDS MARKET 2019-2027 ($ MILLION)
TABLE 35 ASIA PACIFIC CARDIOVASCULAR DISORDERS MARKET 2019-2027 ($ MILLION)
TABLE 36 ASIA PACIFIC OTHER THERAPEUTIC APPLICATIONS BACK 2019-2027 ($ MILLION)
TABLE 37 ASIA PACIFIC STEM CELL MARKET BY TREATMENT TYPE 2019-2027 ($ MILLION)
TABLE 38 ASIA PACIFIC ALLOGENEIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 39 ASIA PACIFIC AUTOLOGIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 40 ASIA PACIFIC SYNGENEIC STEM CELL THERAPY MARKET 2019-2027 ($ MILLION)
TABLE 41 ASIA PACIFIC STEM CELL MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 42 STEM CELL RESEARCH POLICIES IN SOME ASIAN COUNTRIES

List of Figures

LIST OF FIGURES
FIGURE 1 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 2 ASIA PACIFIC ADULT STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 3 ASIA PACIFIC ADULT STEM CELL MARKET BY HEMATOPOIETIC STEM CELL 2019-2027 ($ MILLION)
FIGURE 4 ASIA PACIFIC ADULT STEM CELL MARKET BY MESENCHYMAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 5 ASIA PACIFIC ADULT STEM CELL MARKET BY NEURAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 6 ASIA PACIFIC ADULT STEM CELL MARKET BY DENTAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 7 ASIA PACIFIC ADULT STEM CELL MARKET BY UMBILICAL CORD STEM CELL 2019-2027 ($ MILLION)
FIGURE 8 ASIA PACIFIC STEM CELL MARKET BY HUMAN EMBRYONIC STEM CELL 2019-2027 ($ MILLION)
FIGURE 9 ASIA PACIFIC STEM CELL MARKET BY INDUCED PLURIPOTENT STEM CELL 2019-2027 ($ MILLION)
FIGURE 10 ASIA PACIFIC STEM CELL MARKET BY RAT NEURAL STEM CELL 2019-2027 ($ MILLION)
FIGURE 11 ASIA PACIFIC STEM CELL MARKET BY ACQUISITION 2019-2027 ($ MILLION)
FIGURE 12 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY BONE MARROW 2019-2027 ($ MILLION)
FIGURE 13 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY CELL APHERESIS 2019-2027 ($ MILLION)
FIGURE 14 ASIA PACIFIC STEM CELL ACQUISITION MARKET BY UMBILICAL CORD BLOOD 2019-2027 ($ MILLION)
FIGURE 15 ASIA PACIFIC STEM CELL MARKET BY PRODUCTION 2019-2027 ($ MILLION)
FIGURE 16 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY THERAPEUTIC CLONING 2019-2027 ($ MILLION)
FIGURE 17 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY IVF STEM CELL 2019-2027 ($ MILLION)
FIGURE 18 ASIA PACIFIC STEM CELL PRODUCTION MARKET BY STEM CELL CULTURE 2019-2027 ($ MILLION)
FIGURE 19 ASIA PACIFIC STEM CELL MARKET BY STEM CELL CRYOPRESERVATION 2019-2027 ($ MILLION)
FIGURE 20 ASIA PACIFIC STEM CELL MARKET BY STEM CELL EXPANSION AND SUB-CULTURE 2019-2027 ($ MILLION)
FIGURE 21 ASIA PACIFIC STEM CELL MARKET BY REGENERATIVE MEDICINE 2019-2027 ($ MILLION)
FIGURE 22 ASIA PACIFIC STEM CELL MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2019-2027 ($ MILLION)
FIGURE 23 ASIA PACIFIC STEM CELL MARKET BY NEUROLOGICAL DISORDERS 2019-2027 ($ MILLION)
FIGURE 24 ASIA PACIFIC STEM CELL MARKET BY ORTHOPEDIC TREATMENTS 2019-2027 ($ MILLION)
FIGURE 25 ASIA PACIFIC STEM CELL MARKET BY ONCOLOGY DISORDERS 2019-2027 ($ MILLION)
FIGURE 26 ASIA PACIFIC STEM CELL MARKET BY DIABETES 2019-2027 ($ MILLION)
FIGURE 27 ASIA PACIFIC STEM CELL MARKET BY INJURIES AND WOUNDS 2019-2027 ($ MILLION)
FIGURE 28 ASIA PACIFIC STEM CELL MARKET BY CARDIOVASCULAR DISORDERS 2019-2027 ($ MILLION)
FIGURE 29 ASIA PACIFIC STEM CELL MARKET BY OTHER THERAPEUTIC APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 30 ASIA PACIFIC STEM CELL MARKET BY ALLOGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 31 ASIA PACIFIC STEM CELL MARKET BY AUTOLOGIC STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 32 ASIA PACIFIC STEM CELL MARKET BY SYNGENEIC STEM CELL THERAPY 2019-2027 ($ MILLION)
FIGURE 33 ASIA PACIFIC STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 34 INDIA STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 35 CHINA STEM CELL MARKET 2019-2027($ MILLION)
FIGURE 36 JAPAN STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 37 AUSTRALIA STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 38 SOUTH KOREA STEM CELL MARKET 2019-2027 ($ MILLION)
FIGURE 39 REST OF APAC STEM CELL MARKET 2019-2027($ MILLION)
FIGURE 40 STEM CELL MARKET SHARE ANALYSIS OF KEY PLAYERS 2018 (%)

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る